Microbot Medical (FRA:CY9D) Change In Payables And Accrued Expense : €-0.12 Mil (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Microbot Medical Change In Payables And Accrued Expense?

Microbot Medical's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was €0.19 Mil. It means Microbot Medical's Accounts Payable & Accrued Expense increased by €0.19 Mil from Jun. 2024 to Sep. 2024 .

Microbot Medical's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €-0.63 Mil. It means Microbot Medical's Accounts Payable & Accrued Expense declined by €0.63 Mil from Dec. 2022 to Dec. 2023 .

Microbot Medical Change In Payables And Accrued Expense Historical Data

The historical data trend for Microbot Medical's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical Change In Payables And Accrued Expense Chart

Microbot Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.13

-0.20

0.28

-0.23

-0.63

Microbot Medical Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.26	0.05	-0.35	-0.01	0.19

Microbot Medical Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.12 Mil.

Microbot Medical Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Microbot Medical's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbot Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MBOT:USA

Address

288 Grove Street, Suite 388, Braintree, MA, USA, 02184

Website

https://microbotmedical.com

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Microbot Medical Headlines

No Headlines